Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study.

Begg, GA orcid.org/0000-0001-5260-4293, Lip, GYL, Plein, S et al. (1 more author) (2017) Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study. Clinical Biochemistry, 50 (1-2). pp. 11-15. ISSN 0009-9120

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved. This is an author produced version of a paper published in Clinical Biochemistry. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Fibrosis; atrial fibrillation; biomarkers; cardioversion
Dates:
  • Published: January 2017
  • Accepted: 8 September 2016
  • Published (online): 10 September 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Funding Information:
FunderGrant number
British Heart FoundationFS/10/062/28409
Depositing User: Symplectic Publications
Date Deposited: 28 Sep 2016 15:09
Last Modified: 12 Sep 2017 04:12
Published Version: https://doi.org/10.1016/j.clinbiochem.2016.09.008
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.clinbiochem.2016.09.008
Related URLs:

Share / Export

Statistics